Difimicin

Known as: diffimicin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2018
012320082018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Tiacumicin B (1, also known as fidaxomicin or difimicin) is a marketed drug for the treatment of Clostridium difficile infections… (More)
Is this relevant?
Review
2015
Review
2015
BACKGROUND Due to the limitations of existing treatment options for Clostridium difficile infection (CDI), new therapies are… (More)
  • figure 1
  • table 2
Is this relevant?
Review
2014
Review
2014
OBJECTIVE To review the chemistry, pharmacology, microbiology, pharmacodynamics, pharmacokinetics, clinical efficacy… (More)
Is this relevant?
Review
2012
Review
2012
OBJECTIVE To evaluate the pharmacology, microbiology, safety, and efficacy of fidaxomicin for treatment of Clostridium difficile… (More)
Is this relevant?
Review
2012
Review
2012
The two drugs currently recommended for the treatment of Clostridium difficile infection (CDI), namely vancomycin and… (More)
  • figure 1
  • table 1
Is this relevant?
Review
2012
Review
2012
BACKGROUND Fidaxomicin, a macrolide antibiotic, was the first medication for the management of Clostridium difficile infections… (More)
Is this relevant?
Review
2010
Review
2010
OBJECTIVE To evaluate the efficacy and safety of fidaxomicin for the treatment of Clostridium difficile infection. DATA SOURCES… (More)
Is this relevant?
Review
2009
Review
2009
Current drug treatment of Clostridium difficile infection (CDI) focuses on metronidazole and vancomycin. Early studies showed… (More)
Is this relevant?
Review
2008
Review
2008
Recent outbreaks of Clostridium difficile infection (CDI) in North America have been due to a more virulent, possibly more… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?